Tag: AI drug discovery
Biotech Industry Faces Political Uncertainty and AI Profitability Questions at BIO 2026
Biotech executives at BIO 2026 confronted mounting concerns over Chinese competition, the uncertain profitability of AI-driven drug discovery, and political…
AI Drug Development Faces Reality Check as BigHat CEO Debunks Industry Hype
BigHat Biosciences CEO warns that misconceptions about AI capabilities threaten genuine progress in computational drug discovery. Despite $50 billion annual…
Submit Your Paper to GMJ
No APC until January 2027.